Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Is the dismissal of the funding cuts appeal a defeat for pharmacy?

Now the funding cuts court appeal has been dismissed, C+D's editor asks where the sector goes from here

So the final skirmish of the 18-month funding cuts court battle has ended. The casualties include the credibility of the government’s decision-making, the Department of Health and Social Care’s (DH) understanding of community pharmacy, and hundreds of pharmacies that have either closed or are struggling to stay afloat.

The winner? Well in a legal sense that was the government, whose blunt funding cuts withstood a persuasive challenge and appeal.

But pharmacy has surely won the moral victory. Judge Justice Collins dismissed the original court case “with regret” in May 2017, explaining that while some cuts may have been inevitable, the “small number of companies involved” and the quality of the data used to decide how to implement the funding reduction was “less than satisfactory”.

He also predicted that delivery services “may have to cease” – a prophesy that turned out to be eerily prescient.

Hopes for the success of the appeal were subdued from the off, with both former and current CEOs of the Pharmaceutical Services Negotiating Committee (PSNC) stressing that they didn’t want it to derail negotiations for the 2018-19 funding settlement.

So what now? Based on PSNC’s Simon Duke’s comments to C+D, it seems the last barrier to beginning these long-delayed negotiations has now been removed. If there’s cause for optimism, it’s that the recently appointed health secretary Matt Hancock and pharmacy minister Steve Brine both entered their posts long after the cuts were decided and hold no ideological ties to them.

The court battle brought with it unwanted media scrutiny – peaking with Lloydspharmacy’s announcement that it would cease trading at 190 locations – as well as protests from MPs and patients. What better way for the government to draw a line under this debacle than to agree a “fair, realistic and sustainable” (to use Mr Brine’s own words) funding settlement for the sector?

While the government may have won the war, this is the only way they can win the peace.

James Waldron is editor of C+D. Email him at [email protected] or contact him on Twitter at @CandDJamesW

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD001283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel